Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

 

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

 

Persistent Macular Thickening After Ranibizumab Treatment
for Diabetic Macular Edema With Vision Impairment

 

Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab